Skip to main content
. Author manuscript; available in PMC: 2022 Nov 21.
Published in final edited form as: J Am Coll Cardiol. 2014 Dec 30;64(25):2730–2739. doi: 10.1016/j.jacc.2014.09.072

Table 1.

Description of Study Population in Terms of Matching Variables and Demographics

Stented Non-Stented
    N (%) N (%) p-value

OVERALL 9391 (33.3) 18782 (66.7)
Demographics            
 Age Median (IQR) 65 (59–73) 65 (59–73) 0.87
Comorbidities            
 History of CAD Yes 9391 (100.0) 18782 (100.0) 1.00
No 0 (0.0) 0 (0.0)
 History of CHF Yes 2089 (22.2) 4178 (22.2) 1.00
No 7302 (77.8) 14604 (77.8)
 History of Stroke Yes 448 (4.8) 896 (4.8) 1.00
No 8943 (95.2) 17886 (95.2)
 Insulin-Dependent Yes 1432 (15.3) 2864 (15.3) 1.00
No 7959 (84.8) 15918 (84.8)
 Creatinine >2 mg/dl Yes 511 (5.4) 1022 (5.4) 1.00
No 8880 (94.6) 17760 (94.6)
Surgical Characteristics            
 High Risk Surgery* Yes 2151 (22.9) 4302 (22.9) 1.00
No 7240 (77.1) 14480 (77.1)
 Work Relative Value Unit Median (IQR) 15.13 (8.9–21.0) 16.13 (8.8–21.0) 0.97
 Surgery Type** Digestive 2608 (27.8) 5268 (28.1) 0.98
Eye/Ear 6 (0.1) 10 (0.1)
Genital/Urinary 1264 (13.5) 2515 (13.4)
Integumentary 167 (1.8) 322 (1.7)
Musculoskeletal 2078 (22.1) 4196 (22.3)
Nervous 333 (3.6) 658 (3.5)
Other 235 (2.5) 429 (2.3)
Respiratory 297 (3.2) 606 (3.2)
Vascular 2403 (25.6) 4778 (25.4)
Stent Characteristics            
 Stent Type BMS 4929 (52.5)
DES 4350 (46.3)
Both 112 (1.2)
 Stent Indication ACS / MI 2803 (29.9)
ACS / Non-MI 3058 (32.6)
Non-ACS 3530 (37.6)
 Days to Surgery Median (IQR) 332 (150–518)      
*

High risk surgery includes vascular suprainguinal procedures, intrathoracic, or intraperitoneal operations.

**

Controls were also matched by fiscal year of surgery

CAD=Coronary Artery Disease; CHF=Congestive Heart Failure; BMS=Bare Metal Stent; DES=Drug-Eluting Stent; IQR=Interquartile Range